Literature DB >> 4185164

Enhancement of imipramine antidepressant activity by thyroid hormone.

A J Prange, I C Wilson, A M Rabon, M A Lipton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4185164     DOI： 10.1176/ajp.126.4.457

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  28 in total

1.  Brain monoamine synthesis and receptor sensitivity after single or repeated administration of thyroxine.

Authors:  G Engström; U Strömbom; T H Svensson; B Waldeck
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

2.  Effect of neonatal hypothyroidism and delayed L-triiodothyronine treatment on behavioural activity and norepinephrine and dopamine biosynthetic systems in discrete regions of rat brain.

Authors:  R B Rastogi; R L Singhal
Journal:  Psychopharmacology (Berl)       Date:  1979-04-25       Impact factor: 4.530

3.  Postpartum mental syndromes.

Authors:  A Seltzer
Journal:  Can Fam Physician       Date:  1980-11       Impact factor: 3.275

4.  Hyperthyroidism: specifically increased response to central NA-(alpha-)receptor stimulation and generally increased monoamine turnover in brain.

Authors:  U Strömbom; T H Svensson; D M Jackson; G Engström
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

5.  Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women.

Authors:  C M Banki
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

Review 6.  Hormone treatment of depression.

Authors:  Russell T Joffe
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

7.  Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines.

Authors:  R B Rastogi; R L Singhal; Y D Lapierre
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

8.  The effects of desipramine on thyroid hormone concentrations in rat brain.

Authors:  A Campos-Barros; H Meinhold; R Köhler; F Müller; M Eravci; A Baumgartner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

Review 9.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 10.  Risk of adverse events with the use of augmentation therapy for the treatment of resistant depression.

Authors:  I Schweitzer; V Tuckwell
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.